Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Scott, MD, FRCP
Kings College Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
46 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Hlučín, Czechia
- Facility name not stated
Ostrava Trebovice, Czechia
- Facility name not stated
Prague, Czechia
- Facility name not stated
Prague, Czechia
- Facility name not stated
Terezín, Czechia
- Facility name not stated
Uherské Hradiště, Czechia
- Facility name not stated
Zlín, Czechia
- Facility name not stated
Česká Lípa, Czechia
- Facility name not stated
České Budějovice, Czechia
- Facility name not stated
Bad Nauheim, Germany
- Facility name not stated
Freiburg im Breisgau, Germany
- Facility name not stated
Hildesheim, Germany
- Facility name not stated
Leipzig, Germany
- Facility name not stated
Ratingen, Germany
- Facility name not stated
Zerbst, Germany
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Békéscsaba, Hungary
- Facility name not stated
Debrecen, Hungary
- Facility name not stated
Debrecen, Hungary
- Facility name not stated
Esztergom, Hungary
- Facility name not stated
Kecskemét, Hungary
- Facility name not stated
Komárom, Hungary
- Facility name not stated
Miskolc, Hungary
- Facility name not stated
Szombathely, Hungary
- Facility name not stated
Groningen, Netherlands
- Facility name not stated
JD Alkmaar, Netherlands
- Facility name not stated
Rotterdam, Netherlands
- Facility name not stated
Częstochowa, Poland
- Facility name not stated
Elblag, Poland
- Facility name not stated
Katowice, Poland
- Facility name not stated
Lublin, Poland
- Facility name not stated
Sopot, Poland
- Facility name not stated
Swietokrzyce, Poland
- Facility name not stated
Szczecin, Poland
- Facility name not stated
Warsaw, Poland
- Facility name not stated
Warsaw, Poland
- Facility name not stated
Birmingham, United Kingdom
- Facility name not stated
Colchester, United Kingdom
- Facility name not stated
Greenock, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2006
- Primary completion
- —
- Completion
- 30 Apr 2008
- Last update posted
- 13 Mar 2009
- Registered enrollment
- 312
- Registry id
- NCT00296257
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.